HIGHLIGHTS
- who: . et al. from the University of Aberdeen, United Kingdom have published the article: Multitargeting nature of muscarinic orthosteric agonists and antagonists, in the Journal: (JOURNAL) of 20/06/2022
- what: The authors focus on the multiple-target binding of widely used muscarinic drugs that are usually considered subtype-specific.
- how: The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
SUMMARY
Oxotremorine, which is usually considered M1-selective, activates all muscarinic . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.